Traws Pharma, Inc. Cash And Cash Equivalents At Carrying Value

• Traws Pharma, Inc. showed an increase of +8.1% in Cash And Cash Equivalents At Carrying Value from 2015 to 2016.
• This data is from Traws Pharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 29, 2017.
• XBRL data for this metric is available from 2010 to 2016 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2012: $2.52 million | Q3 2012: $108.15 million | Q1 2013: $67.31 million | Q2 2013: $51.18 million | Q3 2013: $76.61 million | Q1 2014: $54.62 million | Q2 2014: $55.50 million | Q3 2014: $42.35 million | Q1 2015: $33.70 million | Q2 2015: $25.36 million | Q3 2015: $22.20 million | Q4 2015: $19.80 million | Q1 2016: $16.84 million | Q2 2016: $12.82 million | Q3 2016: $27.60 million | Q3 2016: $25.78 million | Q4 2016: $21.40 million | Q1 2017: $15.39 million | Q2 2017: $14.99 million | Q3 2017: $7.60 million.
• Over the full 7 years of available data (2010 to 2016), Traws Pharma, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 191.6%.
• Historical annual values: Fiscal year 2016: $21.40 million | Fiscal year 2015: $19.80 million | Fiscal year 2014: $43.58 million | Fiscal year 2013: $60.01 million | Fiscal year 2012: $81.53 million | Fiscal year 2011: $2.71 million | Fiscal year 2010: $7.34 million.
• Data sourced from SEC EDGAR public filings as of August 8, 2026.

Last verified: August 8, 2026